benzocaine
Trade name: Orajel
Approved
Jun 1, 1902
Benzocaine is a local anesthetic. It acts by blocking voltage-gated sodium ion channels in nerve endings. Benzocaine is available over-the counter for local anesthesia of oral and pharyngeal mucous membranes (sore throat, cold sores, mouth ulcers, toothache, sore gums, denture irritation), otic pain, and as a local anesthetic for surgical or diagnostic procedures. As a spray, benzocaine is used for temporary relief of pain and itching associated with minor burns, sunburn, minor cuts or scrapes, insect bites, or minor skin irritations. Topical application of benzocaine to gums or mouth may cause rare, but serious and potentially fatal adverse effect methemoglobinemia. — NCATS
Clinical trial activity
47 trials · 52 clinical orgs · 0 marketing orgs
Earliest trial started Aug 1, 2004 (NCT01544842)
Timeline
Indications
Studied for
- Analgesia · Phase 4
- Anesthesia · Phase 4
- Anesthesia, Dental · Phase 1/Phase 2
- Anesthesia, Local · Phase 2
- Asthma · Phase 2
- Breast Feeding · Phase 1/Phase 2
- Catheters · Phase 3
- Drug-Related Side Effects and Adverse Reactions · Phase 2
- Eczema · Phase 3
- Intrauterine Devices · Phase 4
- Malabsorption Syndromes · Phase 1
- Mucositis · Phase 2
- Nasolabial Fold · Phase 4
- Neonatology · Phase 1/Phase 2
- Obesity · Phase 1
- Otitis Media · Phase 3
- Pain · Phase 4
- Pain Management · Phase 2
- Pediatric Dentistry · Phase 2
- Pharmacokinetics · Early Phase 1
- Pharyngitis · Phase 4
- Postoperative Pain · Phase 4
- Pulpitis · Phase 2
- Quadriceps Muscle · Early Phase 1
- Speech Disorders · Phase 1/Phase 2
- Toothache · Phase 4
Mechanism of action
SCNN1A antagonist
Approval history
- approvedJun 1, 1902
Chemistry & pharmacology
SMILES
CCOC(=O)C1=CC=C(N)C=C1- Mol. weight
- 165.1891 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaBenzocaine ↗
- NCATSU3RSY48JW5 ↗
- ChEMBLCHEMBL278172 ↗
Also known as
- 4-aminobenzoic acid ethyl ester
- 4-aminobenzoic acid ethyl ester
- 4-carbethoxyaniline
- aezodent
- amben ethyl ester
- amben ethyl ester
- americaine
- americaine
- americaine
- anaesthesin
- anaesthesin
- anthisan plus
- ar01
- baby anbesol
- baby anbesol
- benzocaina
- benzocaina
- benzocaine
- benzocaine
- benzocaine
- benzocaine
- benzocaine
- benzocaine
- benzocaine
- benzocaine
- benzocaine
- benzocaine formate
- benzocaine hcl
- benzocaine hydrobromide
- benzocaine hydrochloride
- benzocaine methanesulfonate
- benzocainum
- benzocainum
- burneze
- children's chloraseptic
- dequacaine
- ethyl aminobenzoate
- ethyl aminobenzoate
- ethyl aminobenzoate
- ethyl aminobenzoate
- ethyl p-aminobenzoate
- ethyl p-aminobenzoate
- ethyl p-aminophenylcarboxylate
- ethyl p-aminophenylcarboxylate
- lanacane
- lanacane
- medilave
- medilave
- nestosyl
- nestosyl
- norcaine
- orajel
- parathesin
- p-carbethoxyaniline
- p-carbethoxyaniline
- p-(ethoxycarbonyl)aniline
- p-(ethoxycarbonyl)aniline
- p-ethoxycarboxylic aniline
- p-ethoxycarboxylic aniline
- tyrosolven
- tyrozets
- tyrozets
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06951191 | Phase 4 | Jun 23, 2025 | University of Missouri |
| NCT06691269 | N/A | Jan 31, 2025 | University of Maryland |
| NCT06804616 | Early Phase 1 (Phase 1) | Nov 28, 2024 | University of Health Sciences Lahore |
| NCT06272903 | Early Phase 1 (Phase 1) | Mar 31, 2024 | Mohammed Bin Rashid University of Medicine and Health Sciences |
| NCT06011005 | N/A | Sep 1, 2023 | Mohammed Bin Rashid University of Medicine and Health Sciences |
| NCT05507359 | N/A | Mar 1, 2023 | Cairo University |
| NCT05861154 | N/A | Dec 1, 2022 | Alexandria University |
| NCT05564442 | N/A | Jun 5, 2022 | Minia University |
| NCT05083975 | N/A | Dec 31, 2021 | Cairo University |
| NCT05060913 | Early Phase 1 (Phase 1) | Nov 17, 2021 | Dow University of Health Sciences |
| NCT06165432 | Phase 4 | Mar 19, 2021 | B.P. Koirala Institute of Health Sciences |
| NCT04859738 | Phase 3 | Mar 4, 2020 | Erciyes University |
| NCT04308161 | Phase 2 | Nov 2, 2019 | Alexandria University |
| NCT04317508 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2019 | Alexandria University |
| NCT04095442 | Early Phase 1 (Phase 1) | Oct 31, 2019 | Indiana University |
| NCT04317183 | Phase 2 | May 15, 2019 | Alexandria University |
| NCT03790540 | Phase 2 | Dec 1, 2018 | Alexandria University |
| NCT03432923 | Phase 3 | Feb 2, 2018 | Janssen Pharmaceutica NV, Johnson and Johnson |
| NCT03833570 | Phase 2 | Jan 12, 2018 | Alexandria University |
| NCT03953001 | N/A | Jan 1, 2018 | Imam Abdulrahman Bin Faisal University |